Javascript must be enabled to continue!
Haemodynamic gain index and heart failure incidence- Prognostic and preventive value
View through CrossRef
Abstract
Aims
Heart failure (HF) is a non-curable, life-threatening condition, characterized by impaired haemodynamic function and poor survival. This study aimed to assess the association between haemodynamic gain index (HGI) and HF incidence in men.
Methods and results
Exposure was HGI, [(HRpeak*SBPpeak) − (HRrest*SBPrest)]/(HRrest*SBPrest) measured from treadmill exercise testing in 5539 men aged 59 ± 11.5 years who were free from HF at baseline. The outcome was the incidence of HF. Cox hazard models adjusted for established risk factors were analysed for the association between HGI and HF. During 14.3 ± 6 years of follow-up, 297 cases of HF occurred (average annual incidence rate 3.7 events per 1000 person-years) and average HGI was 1.6 ± 0.7 bpm/mmHg. In a continuous model, every one unit higher in HGI was associated with a 44% [hazard ratio 0.56, 95% confidence interval (0.45–0.69), P < 0.001] lower risk of HF incidence. In a categorical model, compared with those in quartile-4 (HGI > 2.0), those in quartile-3 (HGI 1.51-2.0), quartile-2 (HGI 1.05-1.5), and quartile-1 (HGI < 1.05) exhibited 70%, 220%, and 280% higher risks for developing HF, respectively (P trend < 0.001).
Conclusion
HGI was found to be a strong predictor of HF incidence in men, supporting its prognostic value. Higher HGI was independently associated with lower risk of HF incidence, while low HGI could serve as a prognostic risk factor for HF. Integrating HGI in the screening and early detection paradigm and referring individuals with low HGI to exercise rehabilitation could potentially enhance public health and prevention strategies against HF.
Oxford University Press (OUP)
Title: Haemodynamic gain index and heart failure incidence- Prognostic and preventive value
Description:
Abstract
Aims
Heart failure (HF) is a non-curable, life-threatening condition, characterized by impaired haemodynamic function and poor survival.
This study aimed to assess the association between haemodynamic gain index (HGI) and HF incidence in men.
Methods and results
Exposure was HGI, [(HRpeak*SBPpeak) − (HRrest*SBPrest)]/(HRrest*SBPrest) measured from treadmill exercise testing in 5539 men aged 59 ± 11.
5 years who were free from HF at baseline.
The outcome was the incidence of HF.
Cox hazard models adjusted for established risk factors were analysed for the association between HGI and HF.
During 14.
3 ± 6 years of follow-up, 297 cases of HF occurred (average annual incidence rate 3.
7 events per 1000 person-years) and average HGI was 1.
6 ± 0.
7 bpm/mmHg.
In a continuous model, every one unit higher in HGI was associated with a 44% [hazard ratio 0.
56, 95% confidence interval (0.
45–0.
69), P < 0.
001] lower risk of HF incidence.
In a categorical model, compared with those in quartile-4 (HGI > 2.
0), those in quartile-3 (HGI 1.
51-2.
0), quartile-2 (HGI 1.
05-1.
5), and quartile-1 (HGI < 1.
05) exhibited 70%, 220%, and 280% higher risks for developing HF, respectively (P trend < 0.
001).
Conclusion
HGI was found to be a strong predictor of HF incidence in men, supporting its prognostic value.
Higher HGI was independently associated with lower risk of HF incidence, while low HGI could serve as a prognostic risk factor for HF.
Integrating HGI in the screening and early detection paradigm and referring individuals with low HGI to exercise rehabilitation could potentially enhance public health and prevention strategies against HF.
Related Results
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Objective: To determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population...
Etiology and predictors of heart failure in pregnancy. Newer Insights from the M-PAC registry
Etiology and predictors of heart failure in pregnancy. Newer Insights from the M-PAC registry
Abstract
Background
Women with heart disease undergoing pregnancy is on the increase, along with an increasing cardiac contribut...
What is heart failure?
What is heart failure?
Abstract
This chapter provides an overview of heart failure. The term ‘heart failure’ is usually used freely between clinicians to describe what is wrong with indivi...
Heart failure monitoring using the wearable cardioverter defibrillator in patients with newly diagnosed heart failure
Heart failure monitoring using the wearable cardioverter defibrillator in patients with newly diagnosed heart failure
Abstract
Funding Acknowledgements
Type of funding sources: None.
Background
...
Empagliflozin in the Real World: Strengthening Heart Failure Care in Pakistan
Empagliflozin in the Real World: Strengthening Heart Failure Care in Pakistan
Heart failure with reduced ejection fraction (HFrEF) remains a major clinical challenge worldwide and is a pressing public health issue in Pakistan. Patients here often present at ...
PATOMEKANISME PENYAKIT GAGAL JANTUNG KONGESTIF
PATOMEKANISME PENYAKIT GAGAL JANTUNG KONGESTIF
Heart failure is a clinical syndrome characterized by abnormalities in the structure or function of the heart, resulting in inability of heart to pump blood to meet the metabolic n...
KEJADIAN PASIEN GAGAL JANTUNG DENGAN PENYAKIT KOMORBID HIPERTENSI DI RSUD ULIN BANJARMASIN
KEJADIAN PASIEN GAGAL JANTUNG DENGAN PENYAKIT KOMORBID HIPERTENSI DI RSUD ULIN BANJARMASIN
Heart failure is a clinical syndrome indicated by the lack of ability of the heart to supply enough blood to the peripheral tissues to fulfill the body's metabolic demands. In some...
Developing and validating a prognostic model for mortality in patients with heart failure
Developing and validating a prognostic model for mortality in patients with heart failure
Abstract
Background
Heart Failure (HF) constitutes a major public health problem which remains highly prevalent in the UK and gl...

